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Abstract
We demonstrate the feasibility of using optical coherence tomography (OCT) to image and detect 
2.8 μm diameter microparticles (stationary and moving) on a highly-reflective gold surface both in 
clear media and under skin in vitro. The OCT intensity signal can clearly report the microparticle 
count, and the OCT response to the number of microparticles shows a good linearity. The detect 
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ability of the intensity change (2.9% ± 0.5%) caused by an individual microparticle shows the high 
sensitivity of monitoring multiple particles using OCT. An optical sensing method based on this 
feasibility study is described for continuously measuring blood sugar levels in the subcutaneous 
tissue, and a molecular recognition unit is designed using competitive binding to modulate the 
number of bound microparticles as a function of glucose concentration. With further development, 
an ultra-small, implantable sensor might provide high specificity and sensitivity for long-term 
continuous monitoring of blood glucose concentration.
Keywords
Biomedical monitoring; magnetic microparticles; optical coherence tomography; skin; 
retroreflection
I. Introduction
Frequent blood glucose monitoring is highly recommended for patients suffering from 
diabetes in order to prevent acute complications and reduce the risk of long-term problems 
[1]. However, the most widely used current sensing method requires collection of a droplet 
of blood from a fingertip through a puncture, which is painful and uncomfortable and acts as 
a deterrent to frequent blood glucose measurements. To improve management of diabetes 
and make blood glucose testing easier and less painful, an implantable (or noninvasive) 
sensor, capable of providing continuous measurement of blood glucose levels, offers the 
opportunity for improved therapeutic interventions [2], [3].
Both electrochemical and optical methods have been extensively studied as possible 
approaches to an implantable (noninvasive) glucose sensor. Owing to concerns for potential 
leaching of mediators, the majority of implantable sensors applying electrochemical 
methods are based on the irreversible oxidation of glucose [4]. Most electrochemical sensors 
have issues of biocompatibility, short storage and operational lifetimes, and response drift 
[4], [5]. Optical methods based on the measurement of photons interacting with tissues have 
certain advantages, such as being free of a reference electrode and consumable reagents, and 
being capable of sterile remote sensing and multiplexing [5], [6]. Optical glucose sensing 
methods can be divided into two broad categories: one approach is to measure the direct 
effects of glucose molecules on the properties of light (e.g. intensity and polarization), and 
the other is to use a molecular recognition technique to transduce the glucose concentration 
into a detectable light signal. Both of these methods have the potential to be developed as a 
noninvasive or implantable optical sensor.
Several optical techniques have been proposed for noninvasive blood glucose sensing [6]–
[8]. Near-infrared (NIR) spectroscopy provides information on glucose concentration by 
measuring the transmission or reflectance of light. As glucose can alter optical absorption 
properties of tissues, changes in the transmission or reflectance spectrum can be linked to 
the changes in blood glucose concentration [9], [10]. However, the tissue absorption 
coefficient also depends on factors such as temperature and changes in the concentration of 
other analytes, which highly affects the accuracy of sensing. Raman spectroscopy derives an 
estimation of glucose concentration through analysing the scattered light influenced by the 
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oscillation and rotation of glucose molecules [11], [12]. Although the Raman spectrum of 
glucose is well differentiable from that of other molecules, the long spectral acquisition time 
and the presence of many other unrelated compounds can strongly limit the clinical 
application of this method. Polarimetry utilizes the optical rotatory dispersion of glucose 
molecules and reflects the blood glucose concentration by measuring the change of the 
polarization plane of linearly polarized light [13], [14]. An anatomic location suggested to 
be well suited for the polarimetric measurement is the anterior chamber of the eye, as the 
scattering of light in the eye is generally very small compared with other types of tissues. 
Problems of this method mainly exist in the interference related to the optical rotation 
effects from the cornea and other optically active components in the aqueous humour. 
Optical coherence tomography (OCT) allows depth-resolved assessment of tissue scattering 
coefficient (which is altered by the changes of glucose concentration) using a low coherence 
interferometer [15]–[18]. But, similar to NIR spectroscopy, varying physiological and 
environmental conditions could also alter the scattering properties of tissue, which highly 
affects the measurement accuracy.
To improve specificity, a major effort has been focused on designing and implementing a 
glucose recognition and reporting unit which can be implanted under the skin and provide a 
detectable light property change caused by the variation of glucose concentration. Methods 
including kinetic enzymatic assays using glucose oxidation [19], [20], chemical binding of 
glucose to synthetic boronic acid [21], [22], affinity binding to Concanavalin A (Con A) 
[23]–[25], and affinity binding to glucose binding proteins [26], [27] have been studied and 
combined with fluorescence, scattering and fiber optic techniques for blood glucose sensing. 
Glucose recognition utilizing affinity binding to Con A offers certain advantages, including 
full reversibility, feasibility of calibration, weak pH-dependence, and no effect of varying 
oxygen partial pressure [5]. Con A is a plant lectin which has four binding sites for glucose 
and carbohydrates (e.g. dextran). Since it was first explored by Schultz et al. using 
fluorescence detection [23], [24], the application of this method has been extensively studied 
with fluorescence labelling and imaging techniques to improve the glucose sensing ability 
with high specificity [25], [28]–[31]. However, nonspecific changes in fluorescence reduce 
the glucose sensing accuracy and reliability.
Recently, Ballerstadt et al. investigated the feasibility of using OCT to monitor the turbidity 
of an implantable glucose recognition unit in order to analyse the glucose concentration 
[32]. The turbidity change is induced by glucose binding to Con A. The glucose-specific 
scattering sensitivity can reach up to 7% mM−1 when measured in air, and remains 0.26% 
mM−1 when tested in a tissue phantom. However, this sensing method may not be able to 
maintain sensing specificity and accuracy when implemented below skin due to the large 
attenuation of the OCT signals from tissue. Also, the aggregation of free Con A will shorten 
the sensor's potential lifetime. Thus, for the purpose of developing highly specific 
implantable glucose sensing method with enhanced sensitivity and long operation time, we 
propose a glucose recognition unit with microparticles-labelled dextran and a highly-
reflective gold mirror coated with Con A. The gold mirror surface is used to provide a strong 
reflection signal for maintaining sufficient sensing accuracy after implantation (for the final 
construction, we intend to utilize a micro-retroreflector-based gold platform [33], which is 
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able to provide high contrast for the detection of reflected light within tissue). The 
immobilization of Con A on the gold mirror surface greatly reduces its aggregation rate and 
therefore extends the effective sensing lifetime. For housing the unit, a semi-permeable 
membrane can be applied to allow free diffusion of glucose molecules while being 
impermeable to cells and microparticles. A schematic of the proposed structure is shown in 
Figure 1. Glucose recognition is realized by competitive displacement of glucose and 
microparticles-labelled dextran to Con A. With different glucose concentration, the binding 
competition of glucose and dextran to Con A will modulate the microparticle density within 
the imaging area on the gold mirror surface. Due to the reversible property of competitive 
binding [34], specifically, lower glucose concentration will enable more microparticles to be 
localized on the surface, and increasing glucose concentration will reduce the amount of 
microparticles. Therefore, through monitoring the number of microparticles within the target 
area, glucose concentration can be determined. For continuous glucose monitoring, the 
sensing unit is expected to be implanted in the upper layer of the dermis, located 
approximately 150–300 μm from the skin surface (illustrated in Figure 1).
More recently, we have demonstrated that OCT has the capability of depth-resolved imaging 
of highly-reflective micro-structures under tissue up to 910 μm in depth [35], and, thus, OCT 
could be used to detect the change of the reflection of light from a gold mirror surface under 
tissue and to monitor the microparticle number based on the scattering properties of these 
particles. Since we expect that the glucose concentration can be well represented by the 
amount of bound microparticles, the sensitivity and specificity of the proposed sensing 
system are highly dependent on how well the microparticles can be resolved by OCT and 
how well the signal from OCT and the microparticle density are correlated. In this paper, we 
show results from a feasibility study where we focused on the quantification of the reflection 
variation caused by the change of microparticle number on a mirrored surface and also the 
monitoring of the microparticles both in clear media and under skin tissue using OCT.
II. Materials and Methods
A. Microparticles
For the proposed sensing method, the microparticles should be small in size, easy to 
manipulate, and able to be coated with dextran. Thus, our primary selection focused on 
Dynabeads with carboxylic acid groups (Life Technologies Corporation). Two available 
sizes with 1.05 μm and 2.8 μm diameter are suitable for the construction of the sensing unit. 
Also, their superparamagnetic property allows the use of magnets to control the 
microparticles’ position within the capsule. It is well known that the attenuation of the light 
is dependent, among others, on the diameter of the scatters and the wavelength of the light 
[36]. Typically OCT employs the central wavelengths around 800 nm and 1300 nm [37]. 
Thus, we performed a preliminary study of light attenuation versus microparticle 
concentrations using two OCT systems with the laser sources around these wavelengths. 
Fig. 2 shows the dependence of the attenuation coefficient on microparticle concentrations 
for the 1.05 μm and the 2.8 μm diameter microparticles using OCT system centered at 840 
nm and 1325 nm. A linear fit was applied to the data to quantify the slope of the change, and 
it can be seen that, in Fig. 2(c), the change of attenuation coefficient appears to have the 
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highest slope. Moreover, for the low concentration range (≤200 particles/nL), the slope in 
Fig. 2(c) is even steeper. This result indicates the sensitivity of the attenuation coefficient to 
the changes in microparticle number is greatest for microparticles with 2.8 μm in diameter at 
a central wavelength of 840 nm. Thus, based on this test, Dynabeads M-270 Carboxylic 
Acid (2.8 μm diameter) was chosen for the feasibility study of the proposed sensing method.
B. OCT System and en Face OCT Imaging
A spectral domain OCT system with the central wavelength of 840 nm was chosen for use in 
this study based on the preliminary data described in Fig. 2. The schematic of the system is 
shown in Fig. 3. The laser source (superluminescent diode) has a bandwidth of ~49 nm with 
the output power of around 20 mW. The OCT system is based on a Michelson 
interferometer where the light from the reference and the sample arms interference. A home-
built spectrometer is utilized to resolve the wavelengths and detect the interference fringes. 
In the spectrometer, the collimated beam falls onto a 1200 l/mm holographic transmission 
grating, and the beam with spatially-separated wavelengths is focused onto the 2048 pixels 
of a CCD. The data acquisition from the CCD is synchronized with the Galvo mirrors in the 
sample arm that are used for the two-dimensional transverse scan of the sample. The A-line 
(depth-resolved imaging) speed of the OCT system can reach up to 29 kHz. An axial 
resolution of ~12 μm (in air) and a transverse resolution of ~8 μm can be achieved. The 
maximum imaging depth in scattering tissues (assuming refractive index of 1.4) is around 3 
mm.
The position of the gold mirror surface can be located and selected from the depth-resolved 
OCT images and the intensity of the OCT signal at this particular depth represents the 
reflection from the gold mirror surface. Because the light scattering from the microparticles 
reduces the intensity of the localized reflected light from the gold mirror surface, an en face 
OCT image with the information of reflection shows the microparticle distribution across 
the gold mirror surface.
C. Gold Mirror
To create gold mirror surfaces, 100 mm diameter silicon wafers were coated with a 10 nm 
thick layer of titanium followed by a 100 nm thick layer of gold deposited using thermal 
evaporation.
D. Mouse Ear
Skin from a mouse ear was used in the in vitro studies. A mouse ear was dissected and kept 
in 0.9% saline before experiments. During experiments, distilled water was added to avoid 
dehydration. Based on the measurement from OCT three-dimensional images, the skin tissue 
from the mouse ear had a thickness of 150–300 μm.
E. Experimental Procedure
The experiments for the feasibility study of the proposed glucose sensing method were 
performed in three phases.
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1) Assessing the variation of intensity from OCT signal with the change of 
microparticle number on the gold mirror surface. Low-concentration (1×103 
particles/μL – 1× 105 particles/μL) microparticle solutions were prepared and 
deposited on the surface of gold mirrors. The mirrors were marked with cross-
shaped scratches to provide reference positions. After the microparticles were 
allowed to dry on the gold mirror, an optical microscope and the OCT system 
were used to image the same regions. The mapping of the microparticles on the 
gold mirror surface using en face OCT images was examined by the 
corresponding microscope images. Based on the mapping results, the change of 
intensity from OCT signal at the microparticle locations was quantified.
2) Imaging and detecting the movement of microparticles in clear media. A low-
concentration microparticle solution (1 mL, 200 particles/μL) was prepared and 
deposited on the gold mirror surface of ~172 mm2 area. The microparticles 
settled on the mirror surface before the OCT recording was started. The OCT 
imaging area was set to be 935 × 187 μm2 with a scanning interval of ~2.3 μm. 
The imaging speed was 2 seconds per two-dimensional scan. A magnetic field 
was applied at the time around 3.5 minutes after the recording started. The 
average of the intensity of OCT signal from the gold mirror surface in each two-
dimensional scan was obtained and recorded over time. Also, en face OCT 
images at different time points were generated.
3) Detecting and monitoring the movement of microparticles under skin tissue in 
vitro. The skin tissue from a mouse ear was placed on the gold mirror, and a 
microparticle solution of 200 particles/μL was added between the tissue and the 
gold mirror surface, forming a layer with a thickness of about 0.7–1.0 mm. The 
experimental setup is shown with a picture in Fig. 4(a). An area of 935×187 μm2 
was scanned by the OCT system, and a typical three-dimensional OCT image, 
including the gold mirror surface and the skin tissue, is shown in Fig. 4(b). The 
OCT transverse scanning interval was also kept at ~2.3 μm and the recording 
time for each two-dimensional scan was 2 seconds. Similar to the second phase, 
the average of the intensity of OCT signal from the gold mirror surface in each 
two-dimensional scan was plotted over time for both before and after applying 
the magnetic field.
III. Results and Discussions
Selected typical en face OCT images of microparticles deposited on the gold mirror surface 
are shown in Fig. 5(a) and (c). The corresponding optical microscope images of the same 
imaging regions are shown in Fig. 5(b) and (d). The locations of the cross-shaped scratches 
offered the references for the mapping of the microparticles. Fig. 5 shows that OCT is able 
to correctly map the distribution of microparticles on the gold mirror surface. The clusters of 
three microparticles and the corresponding dark points in the en face OCT images are called 
out with the black arrows in Fig. 5.
By mapping the intensity signals from the OCT scan to the actual microparticle count, the 
fractional decrease in the intensity of OCT signal was calculated for single microparticles 
Wang et al. Page 6
IEEE Sens J. Author manuscript; available in PMC 2015 September 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
and aggregates containing a variety of microparticle counts. The result is shown in Fig. 6. 
For single microparticles and aggregates with 2–8 microparticles, N = 4 (samples for 
measurement). Since the aggregates with more microparticles are rare, for aggregates with 9, 
10 and 11 microparticles, N = 1 (sample for measurement). Fig. 6 shows that when the 
number of microparticles increases, the intensity decreases with an approximately linear (R 
= 0.89) relationship. The intensity change caused by one single microparticle is 2.9% ± 
0.5%. These results indicate that OCT has the ability to assess the microparticle number 
through detecting the change of local reflection. Also, the detectable individual 
microparticle with an intensity decrease of 2.9% ± 0.5% suggests a high sensitivity of using 
OCT to identify single microparticle on the gold mirror surface.
In the next experiments, we investigated the feasibility of using OCT to detect the 
movement of microparticles through both clear media and skin tissue in vitro. Fig. 7 shows 
the typical result from the experiments of monitoring microparticles through water. The 
intensity information of the OCT signal from the gold mirror surface can represent the state 
of the microparticles within the scanning region. The intensity (averaged from two-
dimensional scanning area) detected from the gold mirror surface covered with only water 
was first recorded and used as the reference value for normalization. From Fig. 7(a), it can 
be seen that during the time range of 0–3.5 minutes, the signal has a relatively high 
frequency and small amplitude of variation, which we attribute to the Brownian motion of 
the microparticles in water. When a mag netic field is applied at about 3.5 minutes into the 
experiment, the microparticles start to form long chains (similar as the phenomenon 
observed in [38]) and move into the direction of the magnet, which can be observed in Fig. 
7(b) and (c). As the microparticles are pulled out from the scanning region, shown in Fig. 
7(c), (d) and (e), the intensity signal increases over time, and remains relatively constant 
after about 14 minutes. During the time of 14–17 minutes, the left several clusters of 
microparticles cannot be moved by the magnetic field and maintain stable on the gold mirror 
surface, as shown in Fig. 7(f) and (g). The fluctuation of the intensity signal during different 
periods in the experiment is analyzed in Fig. 7(h). For each period, the percentage of the 
signal fluctuation was calculated with the standard deviation of the normalized intensity 
divided by the relevant averaged value. From Fig. 7(h), it can be seen that the fluctuation of 
the signal from 0–3.5 minutes and 14–17 minutes is much smaller than the one during 3.5–
14 minutes when the magnetic field was just applied to the microparticles. This is because 
large amounts of microparticles in clusters were driven out of and also into the scanning 
region from the time of 3.5–14 minutes, which resulted in the signal fluctuation with 
relatively very high amplitude and low frequency, as shown in Fig. 7(a). It can also be 
observed that the fluctuation of the signal during 14–17 minutes appears to be half smaller 
than the one during 0–3.5 minutes. This can be explained by the fact that during the last 
three minutes, there were fewer microparticles present in the scanning region, which 
indicates the overall Brownian motion of the microparticles during this period is much less 
than the one during the time of 0–3.5 minutes. These results indicate that the state of 
microparticles on the gold mirror surface can be clearly monitored over time through clear 
media based on the intensity information of the OCT signal.
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The result from the experiment of detecting the movement of microparticles under skin 
tissue in vitro is presented in Fig. 8. The averaged intensity value from each two-
dimensional scan is plotted over time to represent the state of microparticles under tissue 
before and after applying the magnetic field. Similar to the result presented in Fig. 7, during 
0–2 minutes (before the magnetic field was applied), the variation of the intensity signal 
appears to have lower amplitude and higher frequency relative to the one from the time of 
2–4 minutes when the magnetic field was applied, as shown in Fig. 8(a). This is caused by 
the movement of microparticle clusters over the scanning region. Also, similarly, it can be 
observed that the averaged intensity increases to a higher value after the magnetic field was 
applied, due to fewer microparticles remaining within the scanning region. These are also 
indicated in Fig. 8(b) where the intensity signals are compared before and after applying the 
magnetic field. The percentage of the signal fluctuation has been calculated to be 0.6% and 
1.0% for the time periods before and after the magnetic field was applied, respectively. This 
is comparable with the data presented in Fig. 7(h). The differences (0.6% to 0.4% and 1.0% 
to 1.5%) can be a result of the variation of the light scattering from skin tissue over the 
monitoring period. The result presented in Fig. 8 demonstrates that OCT can be utilized to 
detect the movement of microparticles over time on the gold mirror surface under skin tissue 
in vitro.
These results from the feasibility study belong to the first phase in our goal of developing 
optical implantable sensing method to continuously monitor the blood sugar levels in the 
subcutaneous tissue. The disadvantage of using gold mirror lies in the challenges to position 
the gold mirror surface perpendicular to the laser beam as well as to maintain exactly the 
same scanning region during multiple times of measurements. Regarding this problem, a 
micro-retroreflector-based gold platform with a fixed distribution pattern has been designed 
and manufactured to provide highly-reflected light and also the possibility of implantation 
[33]. For the imaging with OCT, the platform has been demonstrated to be able to offer 
well-specified region and good signal-to-noise ratio [35].
The proposed glucose sensing method consists of two information-transducing steps. The 
first one is from the glucose concentration to the number of microparticles through a 
competitive displacement process, and the second one is from the microparticle number to 
the intensity of OCT signal. The presented results focus on the latter step and have 
demonstrated the feasibility of using OCT to detect and monitor microparticles on the gold 
mirror surface both in clear media and under skin tissue in vitro. Based on our recent 
preliminary experiments using micro-channels, we have also observed that the dextran-
coated microparticles with a diameter of ~3 μm bind efficiently onto the gold surface that is 
functionalized with Con A. Additionally, the presence of glucose results in a decrease in the 
number of bound microparticles on the gold surface due to a reduction in the number of 
available binding sites on the Con A-functionalized surface. In the future, our work will 
focus on optimizing the chemistry for sensing glucose. We also plan to integrate our 
approach with micro-retroreflector-based sensing elements and to investigate the 
relationship between the OCT intensity signal and the glucose concentration.
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IV. Conclusion
We describe the concept of a new optical glucose sensing method for continuous monitoring 
blood sugar levels in the upper dermis layer. The method is based on the competitive 
binding of glucose and microparticles-labelled dextran to Con A immobilized on the surface 
of a highly-reflective implantable gold platform. With the reversible binding process, an 
increase in glucose concentration reduces the amount of microparticles within the target 
region on the gold mirror surface. Due to the light scattering property of microparticles, the 
information of microparticle number can be revealed by detecting the change of light 
reflection from the gold mirror surface using OCT. The diameter of the microparticles and 
the central wavelength of OCT system are optimized for the sensitivity of the detection. The 
feasibility of using OCT to detect and monitor the microparticles on the gold mirror surface 
has been demonstrated both in clear media and through skin tissue in vitro. The detectable 
intensity change of 2.9% ± 0.5% caused by an individual microparticle suggests a high 
sensitivity of microparticle detection using OCT. With further development, the proposed 
method can potentially offer improved sensitivity and convenience for the everyday blood 
glucose monitoring.
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Fig. 1. 
Illustration of the sensing element construction and implantation position. The picture of 
skin anatomy on the right is from National Cancer Institute (for free reuse), http://
visualsonline.cancer.gov/details.cfm?imageid=4604.
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Fig. 2. 
Attenuation coefficient of (a) 1.05 μm diameter microparticles measured with 840 nm 
central wavelength OCT system, (b) 1.05 μm diameter microparticles measured with 1325 
nm central wavelength OCT system, (c) 2.8 μm diameter microparticles measured with 840 
nm central wavelength OCT system, and (d) 2.8 μm diameter microparticles measured with 
1325 nm central wavelength OCT system. N = 50 for the times of measurements presented 
in (a), (b), (c) and (d).
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Fig. 3. 
Schematic of the spectral domain OCT system used for microparticles monitoring; L-laser, 
FOC-fiber optic coupler, FA-fiber adaptor, AL-achromatic lens, TG-transmission grating, C-
collimator, A-aperture, M-mirror, GM-X/Y-Galvo mirror-X/Y, SL-scan lens, S-sample, 
LS-2D-linear stage-two-dimension.
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Fig. 4. 
(a) Experimental setup for studying the OCT monitoring of microparticles’ movement under 
mouse ear skin tissue in vitro. (b) Three-dimensional OCT image showing the mouse ear 
skin tissue and the gold mirror surface with a vertical distance of 0.7–1.0 mm between them.
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Fig. 5. 
(a) and (c) are en face OCT images of microparticles deposited on the gold mirror surface; 
(b) and (d) are the corresponding microscopic images of microparticles deposited on the 
gold mirror surface. The scale bars are 100 μm long and the black arrows point to the dark 
points, which correspond to the clusters of three microparticles. Partially magnified pictures 
from (b) and (d) are squared with yellow color.
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Fig. 6. 
(a) A plot of intensity change vs. different number of microparticles in aggregates. For 
single microparticles and aggregates with 1–8 microparticles, N = 4 (samples for 
measurement). For aggregates with 9, 10 and 11 microparticles, N = 1 (sample for 
measurement). (b) Optical microscope images of microparticle aggregates used for 
quantifying the fractional decrease of the intensity of OCT signal.
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Fig. 7. 
(a) Normalized intensity profile over time indicating the movement of microparticles on the 
gold mirror surface in clear media (signal normalized to the averaged intensity value with 
water alone). (b)—(g) En face OCT images selected from different time points. (h) The 
fluctuation of intensity during four periods: reference state (water alone), 0-3.5 min (before 
applying magnetic field), 3.5–14 min (microparticles moving in the magnetic field), and 14–
17 min (clusters of microparticles left stable in the magnetic field).
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Fig. 8. 
(a) Intensity profile over time indicating the movement of microparticles on the gold mirror 
surface under skin tissue in vitro (intensity averaged from the OCT two-dimensional 
scanning area). (b) Comparison of the intensity values before (0–2 min) and after (2–4 min) 
applying the magnetic field.
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